8K 4.22.2014


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

 


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report:  April 22, 2014
(Date of earliest event reported)
 
 


BIO-RAD LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
 

 


Commission File Number: 1-7928
 
Delaware
 
94-1381833
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
1000 Alfred Nobel Dr.
Hercules, California 94547
(Address of principal executive offices, including zip code)
 
(510) 724-7000
(Registrant’s telephone number, including area code)
 
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))











ITEM 5.07 Submission of Matters to a Vote of Security Holders.
 
 
Bio-Rad Laboratories, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 22, 2014. The matters voted upon at the meeting and the results of those votes are set forth below.

1. Each of the nominated directors was elected and received the affirmative vote of a majority of the votes cast in the respective class of Common Stock, as follows:
 
 
 
 
 
 
 
Class of
 
 
 
 
 
Common Stock
Votes
Votes
Votes
Broker
 
to Elect
For
Against
Abstaining
Non-Votes
 
 
 
 
 
 
Louis Drapeau
Class A
12,416,236
7,838,817
52,687
1,717,551
Robert M. Malchione
Class A
19,815,190
440,101
52,449
1,717,551
Deborah J. Neff
Class B
4,824,166
7,731
10
173,050
Alice N. Schwartz
Class B
4,821,219
10,678
10
173,050
Norman Schwartz
Class B
4,821,219
10,678
10
173,050
 
 
2. The proposal to select KPMG LLP as the Company’s independent auditors for the fiscal year ending December 31, 2014 was ratified and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows:
 
Votes
Votes
Votes
Broker
 For
Against
 Abstaining
Non-Votes
7,181,040
21,046
5,400
–
 
 
 
 
 
 
 
 
  3. The proposal to amend the Bio-Rad Laboratories, Inc. 2007 Incentive Award Plan to increase the number of shares authorized for sale thereunder by 600,000 and amend the performance criteria included thereunder was approved and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows:
 
 
 
 
 
 
 
 
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
6,555,515
213,811
93,355
344,805
 
 
 
 
 
 
 
 
  4. The advisory resolution on executive compensation was approved and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows:
 
 
 
 
Votes
Votes
Votes
Broke
For
 Against
 Abstaining
Non-Votes
6,555,049
186,326
121,306
344,805
 
 
 
 






SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
Date:
April 25, 2014
 
By:
/s/ Christine A. Tsingos
 
 
 
 
 
Christine A. Tsingos
 
 
 
 
 
Executive Vice President, Chief Financial Officer